HealthQuill
Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio, according to a company statement
Drugs Health Pharma

Biogen Inc. to buy US-based Reata Pharmaceuticals for $7.3 billion

HQ Team July 29, 2023: Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio,.

Read More
Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to the WHO Essential Medicines List.
Drugs Health Pharma

Cancer, multiple sclerosis, Ebola treatments in new WHO Essential Medicines List

HQ Team July 26, 2023: Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to.

Read More
An unusual rise in cases of Guillain-Barré Syndrome (GBS), a rare neurological disorder, has been reported from Peru, which has declared a state of national health emergency, the WHO stated.
Drugs Health Pharma

Guillain-Barré Syndrome cases rising in Peru, cause unknown

HQ Team July 26, 2023: An unusual rise in cases of Guillain-Barré Syndrome (GBS), a rare neurological disorder, has been reported from Peru,.

Read More
Better access to testing and diagnostic services is required to prevent sexually transmitted infections (STI) being acquired by more than one million people every day, the WHO stated.
Drugs Health Pharma

Require access to testing, diagnostic services to control STI: WHO

HQ Team July 26, 2023: Better access to testing and diagnostic services is required to prevent sexually transmitted infections (STI) being acquired by.

Read More
At least 2.5 million people died because of drowning in the last decade and 90% of these deaths occurred in low and middle-income nations, according to the WHO.
Health Medical Pharma

Drowning kills 236,000 people, mostly children, every year globally

HQ Team July 25, 2023: At least 2.5 million people died because of drowning in the last decade and 90% of these deaths.

Read More
Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to treat hypertension in people with high cardiovascular risk.
Drugs Health Pharma

Roche, Alnylam to jointly develop hypertension therapy

HQ Team July 25, 2023: Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to.

Read More
Sixty-seven percent of Sudan’s hospitals are out of service and 10 healthcare workers have died in the internal conflict since mid-April, the WHO stated.
Drugs Health Pharma

Sudan internal strife claims lives of 10 healthcare workers

HQ Team July 25, 2023: Sixty-seven percent of Sudan’s hospitals are out of service and 10 healthcare workers have died in the internal.

Read More
The Middle East Respiratory Syndrome Coronavirus has killed 12 people in the UAE and infected 94 others from July 10, when the first case was reported, according to the WHO.
Drugs Health Pharma

MERS-Coronavirus kills 12 people in the United Arab Emirates   

HQ Team July 25, 2023: The Middle East Respiratory Syndrome Coronavirus has killed 12 people in the UAE and infected 94 others from.

Read More
British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and tablets, cabotegravir, to prevent HIV.
Drugs Health Pharma

Britain’s GSK gets EMA clearance for drug to prevent HIV 

HQ Team July 24, 2023: British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and.

Read More
The reliance of countries on external support for funding initiatives to combat HIV is worrisome, and though new infections and deaths are falling, some nations are experiencing rising incidence, the WHO stated.
Drugs Health Pharma

Challenges to fight HIV remain, funding ‘precarious’: WHO

HQ Team July 24, 2023: The reliance of countries on external support for funding initiatives to combat HIV is worrisome, and though new.

Read More